Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

Breakthroughs in hereditary angioedema management: a systematic review of approved drugs and those under research

Hereditary angioedema (HAE) is a rare genetic disorder, characterized by recurrent and unexpected potentially life-threatening mucosal swelling. The impairment underlying HAE could be a defect in C1-inhibitor activity, or in its serum concentration. Patients affected by HAE should be treated with on...

Full description

Bibliographic Details
Main Authors: Stefania Nicola, Giovanni Rolla, Luisa Brussino
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2019-10-01
Series:Drugs in Context
Subjects:
C1-INH
C1-inhibitor
gene therapy
HAE
hereditary angioedema
lanadelumab
serine protease
SERPING1
Online Access:https://www.drugsincontext.com/breakthroughs-in-hereditary-angioedema-management:-a-systematic-review-of-approved-drugs-and-those-under-research/

Internet

https://www.drugsincontext.com/breakthroughs-in-hereditary-angioedema-management:-a-systematic-review-of-approved-drugs-and-those-under-research/

Similar Items